H.C. Wainwright Reiterates Neutral Rating on Traws Pharma Inc. (TRAW)

August 18, 2026 6:46 AM

H.C. Wainwright analyst Brandon Folkes reiterated a Neutral rating and $1.00 price target on Traws Pharma Inc. (NASDAQ: TRAW).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found